Pulmo BioTech, Inc.
| OTC Markets: PLMO
Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded in 2006 and is headquartered in New York, NY.